natgillin/translations-raw huggingface dataset:
Regarding safety, the CHMP considered that Hexacima’s overall safety profile is similar to other vaccines, although Hexacima is more likely than similar vaccines to cause reactions (mainly at the injection site).
Kar zadeva varnost, je CHMP mnenja, da je celotni varnostni profil cepiva Hexacima podoben drugim cepivom, čeprav je bolj verjetno, da bo cepivo Hexacima povzročilo reakcije (večinoma na mestu injiciranja), kot druga cepiva.
Regarding safety, the CHMP considered that Hexyon’s overall safety profile is similar to other vaccines, although vaccination with Hexyon is more likely than similar vaccines to cause reactions (mainly at the injection site).
Kar zadeva varnost, je CHMP mnenja, da je celotni varnostni profil cepiva Hexyon podoben drugim cepivom, čeprav je bolj verjetno, da bo cepivo Hexyon povzročilo reakcije (večinoma na mestu injiciranja), kot druga cepiva.
Regarding safety, the CHMP considered that the majority of adverse effects with Lenvima can be adequately managed by reducing the dose or temporarily interrupting treatment.
V zvezi z varnostjo je odbor CHMP menil, da je večino neželenih učinkov zdravila Lenvima mogoče zadovoljivo obvladati z zmanjšanjem odmerka ali začasno prekinitvijo zdravljenja.
Regarding safety, the Committee considered that side effects of concern, including haemoptysis and pulmonary haemorrhage, have been adequately reflected in the product information and risk management plan.
V zvezi z varnostjo je odbor menil, da so zadevni neželeni učinki, kot so hemoptiza in pljučne krvavitve, ustrezno obravnavani v informacijah o zdravilu in načrtu obvladovanja tveganj.
Regarding safety, the Committee noted that, although there is limited information in some patient populations such as those with decompensated liver disease (where the liver is damaged and no longer works properly), no side effects specific to Sovaldi have been identified, and those observed are mainly due to combined treatment with ribavirin or interferons.
V zvezi z varnostjo je odbor izpostavil, da so podatki za nekatere populacije bolnikov, na primer za tiste z dekompenzirano boleznijo jeter (poškodovanimi jetri, ki ne delujejo več normalno), sicer omejeni, vendar pa niso odkrili nobenih neželenih učinkov, specifičnih za zdravilo Sovaldi, tisti, ki so jih opazili, pa so bili v glavnem posledica kombiniranega zdravljenja z ribavirinom ali interferoni.
Regarding safety, the side effects of Latuda were considered similar to those of other medicines of the same type, but it seemed to have fewer effects on body metabolism (such as effects on blood levels of sugar and fat, and body weight) and might have less effect on the activity of the heart than some other available treatments.
Kar zadeva varnost, je menil, da ima zdravilo Latuda podobne neželene učinke kot druga zdravila iste vrste, vendar ima manj učinkov na presnovo (kot so na primer učinki na ravni sladkorja in maščob v krvi ter telesno maso) in lahko v manjši meri vpliva na aktivnost srca kot nekatera druga razpoložljiva zdravila.
Regarding safety, the side effects with Uptravi are considered acceptable.
V zvezi z varnostjo so neželeni učinki zdravila Uptravi sprejemljivi.
Regarding safety, while the most common side effects are manageable, the Committee identified liver toxicity as the most important risk with Jinarc, which was addressed by putting in place several measures (see below).
Kar zadeva varnost, so najpogostejši neželeni učinki obvladljivi, vendar je odbor menil, da je najpomembnejše tveganje, povezano z uporabo zdravila Jinarc, toksičnost za jetra, zato je bilo sprejetih več ukrepov (glejte spodaj).
Regarding susceptibility to infection and neoplastic conditions, see section 4.5.
Za dovzetnost za okužbe in neoplastična stanja, glejte poglavje 4.5.
Regarding the 20 mg group, this effect is significant as well, according to ICH guidelines, with upper confidence interval of 10 - 12 ms.
V skupini, v kateri so bolniki prejemali 20 mg zdravila in z zgornjim intervalom zaupanja 10–12 ms, je glede na smernice Mednarodne konference o usklajevanju (ICH) ta učinek prav tako pomemben.
Regarding the dose for a person in close contact with the patient, this is entirely due to the gamma rays (Cuprymina emits 2 gamma rays at 511.0 Kev and 1,345.77 Kev), because β+ and β- emissions have no role due to their very short range.
Količina odmerka na osebo, ki je v tesnem stiku z bolnikom, je popolnoma odvisna od žarkov gama (radiofarmacevtski predhodnik Cuprymina oddaja 2 žarka gama pri 511,0 KeV in 1 345,77 KeV), saj je oddajanje delcev β+ in β- zaradi kratkega dosega zanemarljivo.
Regarding the duration of treatment, your doctor will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Desloratadine Actavis.
Kar zadeva trajanje zdravljenja, bo vaš zdravnik najprej ugotovil vrsto alergijskega rinitisa, ki jo imate, in bo glede na to določil, kako dolgo morate jemati zdravilo Desloratadin Actavis.
Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Aerius oral solution.
Kar zadeva trajanje zdravljenja, bo vaš zdravnik najprej ugotovil vrsto alergijskega rinitisa, ki jo imate, in na podlagi tega določil, kako dolgo naj bi jemali zdravilo Aerius peroralna raztopina.
Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Azomyr oral solution.
Kar zadeva trajanje zdravljenja, bo vaš zdravnik najprej ugotovil vrsto alergijskega rinitisa, ki jo imate, in na podlagi tega določil, kako dolgo naj bi jemali zdravilo Azomyr peroralna raztopina.
Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Neoclarityn oral solution.
Kar zadeva trajanje zdravljenja, bo vaš zdravnik najprej ugotovil vrsto alergijskega rinitisa, ki jo imate, in na podlagi tega določil, kako dolgo naj bi jemali zdravilo Neoclarityn peroralna raztopina.
Regarding the immunotoxic potential, small thymus and thymic involution were observed in dogs in a 13-week study with significant response at the high dose in male.
V zvezi z imunotoksičnim potencialom so pri psih v 13. tednu študije opazili majhen timus in involucijo timusa s značilnim odzivom na visok odmerek pri moških osebkih.
Regarding the risk of bradycardia, further analyses indicated that this risk can occur when sofosbuvir is given with another direct-acting antiviral and amiodarone.
o b upoštevanju tveganja za bradikardijo so nadaljnje analize pokazale, da tveganje lahko nastane, kadar se sofosbuvir uporablja sočasno z drugo učinkovino z direktnim delovanjem na viruse in amiodaronom.
Regarding the safety of Signifor, the identified side effects were considered to be manageable.
Kar zadeva varnost zdravila Signifor, so bili ugotovljeni neželeni učinki ocenjeni kot obvladljivi.
Regarding the safety profile of the medicine, the most frequent side effects reported with Relvar Ellipta were similar to other COPD and asthma treatments; an increased incidence of pneumonia was observed in patients with COPD, and this will be investigated in further studies.
Kar zadeva varnostni profil zdravila, so bili najpogostejši neželeni učinki zdravila Relvar Ellipta, o katerih so poročali, podobni učinkom drugih zdravil za kronično obstruktivno pljučno bolezen in astmo; pri bolnikih s kronično obstruktivno pljučno boleznijo so zabeležili večjo incidenco pljučnic, kar bodo preučevali v nadaljnjih študijah.
Regarding the safety profile of the medicine, the most frequent side effects reported with Revinty Ellipta were similar to other COPD and asthma treatments; an increased incidence of pneumonia was observed in patients with COPD, and this will be investigated in further studies.
Kar zadeva varnostni profil zdravila, so bili najpogostejši neželeni učinki zdravila Revinty Ellipta, o katerih so poročali, podobni učinkom drugih zdravil za kronično obstruktivno pljučno bolezen in astmo; pri bolnikih s kronično obstruktivno pljučno boleznijo so zabeležili večjo incidenco pljučnic, kar bodo preučevali v nadaljnjih študijah.
Regarding the signal myalgia/myopathy, the MAH provided further information on the reported non-serious muscle related events of which the majority concerned myalgia (68 out of the 120 cases reported).
Glede signala mialgije/miopatije je imetnik dovoljenja za promet posredoval dodatne informacije o poročanih dogodkih, povezanih z mišicami, ki niso bili resni, pri katerih je šlo večinoma za mialgijo (68 od 120 poročanih primerov).
Regarding Triumeq’s safety profile, this was expected to be similar to the safety profile of the single components and comparable to that of other HIV treatments.
Kar zadeva varnostni profil zdravila Triumeq, naj bi bil podoben varnostnemu profilu posameznih učinkovin in primerljiv z varnostnim profilom drugih zdravil proti virusu HIV.
Regarding Waldenström’s macroglobulinaemia, Imbruvica had also a clinically relevant effect in previously treated patients, and the CHMP considered that the medicine could also benefit previously untreated patients who are unsuitable for chemo-immunotherapy and for whom no satisfactory treatments are available.
Zdravilo Imbruvica ima klinično pomemben učinek tudi pri bolnikih z Waldenströmovo makroglobulinemijo, ki so že bili zdravljeni, zato je odbor CHMP menil, da bi zdravilo lahko koristilo tudi predhodno nezdravljenim bolnikom, ki ne morejo prejemati kemoimunoterapije in za katere ni na voljo drugega primernega zdravljenja.
Regarding Zavicefta’s safety profile, side effects were those that can be expected for ceftazidime and a beta- lactamase inhibitor.
Kar zadeva varnostni profil zdravila Zavicefta, so neželeni učinki taki, kot jih je mogoče pričakovati pri ceftazidimu in zaviralcu betalaktamaze.
Regarding Zontivity’s safety profile, the CHMP was concerned about the risk of bleeding in patients taking Zontivity on top of their standard therapy, particularly serious bleeding which was more frequent in patients with a history of stroke.
Kar zadeva varnostni profil zdravila Zontivity, je CHMP izrazil zaskrbljenost glede tveganja krvavitev pri bolnikih, ki so prejemali zdravilo Zontivity poleg svojega standardnega zdravljenja, zlasti resnih krvavitev, ki so bile pogostejše pri bolnikih z možgansko kapjo v anamnezi.
Regardless of HLA-B*5701 status, patients who are diagnosed with a hypersensitivity reaction must discontinue abacavir immediately.
Ne glede na status HLA-B*5701, morajo bolniki, pri katerih je ugotovljena preobčutljivostna reakcija, nemudoma prenehati z jemanjem abakavirja.
Regardless of patient weight: yellow hub
22G x 1 ½ palca
Regardless of whether one or two doses of priming vaccine had been given 6 months earlier, the seroprotection rates against A/Indonesia were >80% after a dose of AS03-adjuvanted vaccine containing 3.75 µg HA derived from A/Vietnam/1194/2004 and the seroprotection rates against A/Vietnam were >90% after a dose of AS03-adjuvanted vaccine containing 3.75 µg HA derived from A/Indonesia/05/2005.
Ne glede na to, ali sta bili 6 mesecev prej uporabljena eden ali dva odmerka primarnega cepiva so bili deleži serološke zaščite proti A/Indonesia po odmerku cepiva z adjuvansom AS03 z vsebnostjo 3,75 µg HA pridobljeno iz A/Vietnam/1194/2004 > 80 %, deleži serološke zaščite proti A/Vietnam po odmerku cepiva z adjuvansom AS03 z vsebnostjo 3,75 µg HA pridobljeno iz A/Indonesia/05/2005 pa
Regardless of which strength of NUEDEXTA has been prescribed to you: continue the treatment with: two capsules per day (one capsule every 12 hours).
Ne glede na to, katera jakost zdravila NUEDEXTA vam je bila predpisana: nadaljujte zdravljenje z: dvema kapsulama na dan (ena kapsula na vsakih 12 ur).
Regardless of β2-microglobulin levels at baseline, all efficacy parameters (time to progression and overall survival, as well as response rate) were significantly improved on the bortezomib arm.
Ne glede na koncentracijo β2- mikroglobulina ob začetku zdravljenja so se tudi vsi parametri učinkovitosti (čas do napredovanja bolezni in celokupno preživetje, kot tudi odziv na zdravljenje) v delu preskušanja z bortezomibom statistično značilno izboljšali.
regimen can be used in the
hemo je mogoče
regimen N = 73
Zevalin terapevtska shema n = 73
Regimen Related Mortality (RRM) and Transplant Related Mortality (TRM): low values have been reported, confirming the safety of the conditioning treatments including thiotepa for allogeneic HPCT in adults patients with haematological diseases.
Z režimom povezana umrljivost in s presaditvijo povezana umrljivost: poročali so o nizkih vrednostih, kar potrjuje varnost pripravljalnih zdravljenj s tiotepo za alogensko PKMC pri odraslih bolnikih s hematološkimi boleznimi.
Regimen Related Mortality (RRM) and Transplant Related Mortality (TRM): RRM values ranging from 0% to 2% have been reported.
Z režimom povezana umrljivost in s presaditvijo povezana umrljivost: Poročali so o vrednostih RRM med 0 in 2 odstotkoma.
Regimen Related Mortality (RRM) and Transplant Related Mortality TRM : RRM values ranging from 2.5% to 29% have been reported.
Z režimom povezana umrljivost (RRM: Regimen Related Mortality) in s presaditvijo povezana umrljivost (TRM: Transplant related Mortality): poročali so o vrednostih RRM med 2,5 in 29 odstotki.
regimen, see sections 4.4
C, glejte poglavji
regimens is contraindicated
zdravljenja, ki
regimens with paritaprevir /ritonavir + dasabuvir resulted
encima) in kombinacije paritaprevir/ritonavir + dasabuvir je
regimens with paritaprevir /ritonavir + dasabuvir resulted
induktor encimov) in kombinacije paritaprevir/ritonavir
regimen‡ with
EBR + GZR z RBV.
Regional lymphadenopathy, Thrombocytopenia
področna limfadenopatija, trombocitopenija
Regional pain
regionalna bolečina
Registry
Rezultate
registry are to be
podregistra mora
Registry information sheet.
izobraževalni video, list z registracijskimi podatki.
Regorafenib is an oral tumour deactivation agent that potently blocks multiple protein kinases, including kinases involved in tumour angiogenesis (VEGFR1, -2, -3, TIE2), oncogenesis (KIT, RET, RAF-1, BRAF, BRAFV600E), and the tumour microenvironment (PDGFR, FGFR).
Regorafenib je peroralno zdravilo za zaviranje rasti tumorjev, ki močno zavira multiple proteinkinaze, vključno s kinazami, ki sodelujejo pri angiogenezi (VEGFR1, -2, -3, TIE2), onkogenezi (KIT, RET, RAF-1, BRAF, BRAFV600E) in v mikrookolju tumorja (PDGFR, FGFR).
Regorafenib is eliminated mainly via the hepatic route.
Regorafenib se izloča prevsem skozi jetra.
REGRANEX is a clear colourless to straw-coloured gel.
Zdravilo REGRANEX je bister in brezbarven do rumenkast gel.
Regranex is a clear colourless to straw-coloured gel.
Zdravilo Regranex je prozoren, brezbarven do rumenkast gel.
REGRANEX should not be used continuously for more than 20 weeks.
Zdravila REGRANEX ne smete neprekinjeno uporabljati dlje kot 20 tednov.
Regression to normoalbuminuria (< 30 mg/day) was more frequent in the irbesartan 300 mg group (34%) than in the placebo group (21%).
V skupini s 300 mg zdravila irbesartana je bila pogostejša (34%) regresija na normoalbuminurijo (<30 mg/dan), kot v placebo skupini (21%).
REGULAR - pre
NAVADNI - pred
Regular and fixed times of administration support the patient’s or caregiver’s compliance.
Skladnost z navodili za jemanje je pri bolnikih oz. negovalcih večja, če je jemanje redno in ob isti uri.
Regular blood and urine tests to measure the levels of the body’s important electrolytes are also necessary to help you or your doctor correctly adjust the doses of these supplements.
Redni krvni in urinski testi za merjenje pomembnih elektrolitov v telesu so potrebni tudi zato, ker pomagajo vam oziroma vašemu zdravniku pravilno prilagoditi odmerke omenjenih dodatkov.
Regular blood tests to measure the amount of cystine inside white blood cells are necessary to help determine the correct dose of CYSTAGON.
Redni pregledi krvi z merjenjem količine cistina v belih krvničkah so potrebni za lažje določanje pravilnega odmerka CYSTAGONa.
regular but scanty periods; larger breasts; breast lump; milk production while not pregnant; premenstrual syndrome; pain during intercourse; dryness in the vagina or vulva; spasm of the uterus
redne, a šibke menstruacije, povečanje dojk, bulice v dojkah, nastajanje mleka kljub temu, da ženska ni noseča, predmenstrualni sindrom, bolečine med spolnim odnosom, suhost nožnice ali zunanjega spolovila (vulve), krči maternice
Regular dose
Redni odmerek
Regular dosing every 4–6 hours is recommended when IL-2 is coadministered.
Reden odmerek vsakih 4—6 ur je priporočen v primeru sočasnega dajanja Il-2.
Regular intake of Zoely is then resumed after the yellow placebo tablets have been taken of the second pack.
Po končanem jemanju rumenih placebo tablet iz drugega pretisnega omota naj ženska nadaljuje z običajnim jemanjem zdravila Zoely.
regular monitoring of haemoglobin levels;
rednem spremljanju ravni hemoglobina;
Regular monitoring of liver function is recommended during dinutuximab immunotherapy.
Med imunoterapijo z dinutuksimabom se priporoča redno spremljanje delovanja jeter.
regular monitoring of liver function; the importance of telling patients to report immediately any possible pregnancy that occurs during Opsumit use.
rednem spremljanju delovanja jeter; pomenu takojšnjega poročanja možne nosečnosti, do katere pride med uporabo zdravila Opsumit.
Regular monitoring of the coagulation profile is necessary.
Potrebno je redno spremljanje profila strjevanja krvi.
Regular monthly treatments with Comfortis break the fleas’ life cycle and may be needed to control the flea population in contaminated households.
Redna mesečna zdravljenja z zdravilom Comfortis prekinejo življenjski cikel bolhe in so morda potrebna za obvladovanje populacije bolh v kontaminiranem gospodinjstvu.
Regular monthly treatments with the insecticidal active substance in this product (spinosad) break the fleas’ life cycle and may be used to control the flea population in contaminated households.
Redna mesečna uporaba insekticidne učinkovine v tem zdravilu (spinosada) prekine življenjski cikel bolhe in se lahko uporablja za nadzor populacije bolh v okuženih gospodinjstvih.
Regular monthly treatments with the insecticidal active substance, spinosad, break the fleas’ life cycle and may be used to control the flea population in contaminated households.
Redna mesečna uporaba insekticidne učinkovine spinosad prekine življenjski cikel bolhe in se lahko uporablja za nadzor populacije bolh v okuženih gospodinjstvih.
Regular ophthalmological examinations should be conducted in these patients to detect macular oedema.
Pri teh bolnikih je treba izvajati redne oftalmološke preglede za odkrivanje morebitnega makularnega edema.
Regular review of patients as treatment is stepped down is important.
Pri bolnikih, ki so prešli na zdravljenje z manjšimi odmerki, so pomembni redni pregledi.
Regular review of the administration by the patient and/or caregiver needs to be performed to ensure maintenance of optimal practice.
Da se zagotovi ohranjanje optimalne prakse, so potrebni redni pregledi dajanja zdravila s strani bolnika in/ali negovalca.
Regular review of your/your carer’s injection technique will be performed to ensure continued appropriate handling.
Zdravnik bo tudi redno ocenjeval vašo tehniko injiciranja oziroma tehniko injiciranja vašega negovalca, da bo zagotovljeno stalno ustrezno ravnanje z zdravilom.
Regular screening for steatohepatitis/fibrosis should be performed at baseline and on an annual basis using the following imaging and biomarker evaluations:
Redno presejanje za steatohepatitis/fibrozo je treba opravljati na izhodišču in potem enkrat na leto z uporabo naslednjih oblik slikanja in ocen bioloških označevalcev:
Regular urine analyses should be performed to monitor this event.
Za spremljanje tega pojava je treba redno izvajati preiskave seča.
Regular use of Bretaris Genuair can help you when you have ongoing shortness of breath related to your disease and will help you to minimise the effects of the disease on your everyday life.
Redna uporaba zdravila Bretaris Genuair vam lahko pomaga, kadar imate dolgotrajnejše težave z zadihanostjo, ki je povezana z vašo boleznijo, in vam pomaga zmanjšati učinke bolezni na vaše vsakdanje življenje.
Regular use of Eklira Genuair can help you when you have ongoing shortness of breath related to your disease and will help you to minimise the effects of the disease on your everyday life.
Redna uporaba zdravila Eklira Genuair vam lahko pomaga, kadar imate dolgotrajnejše težave z zadihanostjo, ki je povezana z vašo boleznijo, in vam pomaga zmanjšati učinke bolezni na vaše vsakdanje življenje.
regular uterine contractions of at least 30 seconds duration at a rate of ≥ 4 per 30 minutes
rednimi kontrakcijami maternice, ki trajajo vsaj 30 sekund, s pogostnostjo ≥ 4 na 30 minut;
regular uterine contractions of at least 30 seconds duration at a rate of  4 per 30 minutes
rednimi kontrakcijami maternice, ki trajajo vsaj 30 sekund, s pogostnostjo  4 na 30 minut;
Regularly check your breasts.
Redno pregledujte dojke.
Regularly during your treatment and up to 6 months after your treatment, your doctor needs to check your skin for a type of cancer called “cutaneous squamous cell carcinoma”.
Zdravnik vam mora med zdravljenjem in še 6 mesecev po zdravljenju redno pregledovati kožo zaradi vrste raka, imenovanega "ploščatocelični karcinom kože".
Regulation of CYP450 enzymes
Neželeni učinki
regurgitation (bringing food back up)
regurgitacija (vračanje hrane iz želodca),
regurgitation, increase in stomach aspirate
regurgitacija, zvišan želodčni aspirat
Regurgitation, increased gastric aspirate, necrotising enterocolitis
regurgitacija, zvišan želodčni aspirat, nekrotizirajoči enterokolitis
reinfarction
infarkt.
Reintroduction of Jentadueto should then be discussed taking into account the benefit/risk ratio in an individual basis as well as renal function.
O ponovni uvedbi zdravila Jentadueto se je treba pogovoriti ob upoštevanju razmerja med koristjo in tveganjem pri posamezniku ter delovanja ledvic .
Reintroduction of treatment may be considered if the benefits are considered to outweigh the risks associated with potential liver disease.
O ponovni uvedbi zdravljenja je treba razmisliti le v primeru, če so morebitne koristi večje od tveganj, povezanih z morebitno jetrno boleznijo.
rejection of transplanted bone marrow (frequency unknown)
zavrnitev presajenega kostnega mozga (pogostnost neznana)
rejection of transplanted bone marrow (graft versus host disease)
zavrnitev presajenega kostnega mozga (bolezen presadka proti gostitelju)
rejection of transplanted bone marrow (graft versus host disease)
zavrnitev presajenega kostnega mozga (reakcija presadka proti gostitelju)
rejection of transplanted bone marrow;
zavrnitev presajenega kostnega mozga,
Rejection response to blood transfusions.
zavrnitveni odziv na transfuzijo krvi
Relapse
Ponovitev bolezni
Relapse
Recidiv
Relapse % (n/N)
Recidiv % (n/N)
Relapse %(n/N)
Recidiv % (n/N)
Relapse %, (n/N)
Recidiv % (n/N)
Relapse %, (n/N)
Recidiv %, (n/N)
Relapse free
Brez recidiva
Relapse patients (adults):
Bolniki z relapsom bolezni (odrasli):
Relapse patients: A total of 345 interferon alpha relapse patients were treated in two clinical trials with Viraferon monotherapy or in combination with ribavirin.
Bolniki s ponovitvijo oz. relapsom bolezni: Skupaj 345 bolnikov z interferon alfa relapsom je bilo zdravljenih v dveh kliničnih raziskavah z zdravilom Viraferon, v monoterapiji ali v kombinaciji z
Relapse rate derived variables / MRI-derived variables
Iz stopnje recidivov izpeljane spremenljivke / iz MRT- izpeljane spremenljivke
Relapse was defined as having detectable plasma HCV RNA from planned end of treatment onwards after previous
Ponovitev bolezni je bila določena kot zaznavna koncentracija HCV med spremljanjem, po koncentraciji HCV RNK
Relapse*
Ponovni izbruh bolezni
Relapse** %(n/N)
Recidiv** %(n/N)
Relapse** %, (n/N)
Recidiv** % (n/N)
Relapse5-free survival (RFS) for CR/CRh*
Preživetje brez recidiva5 pri CR/CRh
Relapsec
ponovitev boleznic
Relapsed Ovarian Cancer
Relaps raka jajčnikov
Relapsed SCLC
Relaps drobnoceličnega pljučnega raka